Lifecome Biochemistry Co.,Ltd. (SZSE: 002868)
Health Care · Biotechnology · CN
CN¥22.09
-2.82% today · -21.9% 1Y
Lifecome Biochemistry Co.,Ltd. (SZSE: 002868) operates in the Biotechnology industry within the Health Care sector. The company is valued at $510.70M and employs 549 people.
Over the last twelve months the share price has lost 21.9%, trading between 20.77 and 48.72.
Tweenvest scores Lifecome Biochemistry Co.,Ltd. across four factors: quality 37/100, value 41/100, growth 54/100. Its strongest factor is growth.
002868 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $510.70M
- Revenue (TTM)
- $69.25M
- P/E
- —
- EPS
- -0.47
- Dividend yield
- —
- Beta (5Y)
- 0.79
- 52-week high
- CN¥48.72
- 52-week low
- CN¥20.77
- Avg volume (3M)
- —
- Shares outstanding
- 155.42M
- Employees
- 549
- Next earnings
- —
About Lifecome Biochemistry Co.,Ltd.
Lifecome Biochemistry Co.,Ltd. operates as a biopharmaceutical enterprise within China. The company's diverse product portfolio includes bacitracin zinc, colistin sulfate, probiotics, and bacitracin methylene disalicylate products. It also provides biological preservatives and natamycin. Established in 2003, the firm maintains its base of operations in Pucheng, China.
- Founded
- 2003
- Listed since
- May 3, 2017
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.